Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and

Yuzi Tian1,2, Rachel M Russo1, Yongqing Li3

  • 1Department of Surgery, University of Michigan Health System, University of Michigan Medical School, 1500 E Medical Center Dr. SPC 5331, Ann Arbor, MI, 48109-5331, USA.

Infection
|October 1, 2020
PubMed
Abstract

Insights

Levels of citrullinated histone H3 (CitH3) are elevated in septic shock patients, correlating with disease severity and poor prognosis. This finding offers insights into sepsis pathophysiology and potential diagnostic markers.

Area of Science:

  • Biochemistry
  • Immunology
  • Critical Care Medicine

Background:

  • Microbial infections trigger extracellular trap formation by immune cells, releasing citrullinated histone H3 (CitH3).
  • Peptidylarginine deiminase (PAD) 2 and 4 enzymes catalyze CitH3 formation.
  • Understanding these mechanisms is crucial for developing diagnostics and treatments for septic shock.

Purpose of the Study:

  • To determine CitH3 expression in septic shock patients.
  • To correlate CitH3 levels with PAD2/PAD4 expression.
  • To assess the relationship between CitH3 and clinical outcomes in septic shock.

Main Methods:

  • Serum samples from 160 critically ill patients (septic shock, non-infectious shock) and healthy volunteers were analyzed for CitH3 levels.
  • Clinical and laboratory characteristics of patients were assessed.
  • CitH3 levels were correlated with PAD2/PAD4 concentrations and Sequential Organ Failure Assessment (SOFA) scores.

Main Results:

  • Septic shock patients exhibited significantly higher circulating CitH3 levels compared to non-infectious shock patients.
  • CitH3 levels positively correlated with PAD2, PAD4, and SOFA scores.
  • Elevated CitH3 levels at 24 and 48 hours were associated with non-survival in septic patients.

Conclusions:

  • CitH3 is significantly increased in patients with septic shock.
  • Serum CitH3 concentrations correlate with disease severity and prognosis in sepsis.
  • CitH3 may provide valuable insights into sepsis pathophysiology and serve as a potential biomarker.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
398
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
245
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
642
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
285
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
550